December 26, 2019

Future of Due Diligence in Healthcare M&A

December, 2019

Large corporate mergers and spin-offs, biotech and technology breakthroughs, and stronger-than-ever data privacy requirements make the healthcare sector one rich with opportunity and risk. That means staying on top of due diligence best practices has never been more important.

The good news is that innovative trends are accelerating due diligence across all industries.

Download our latest whitepaper now to explore:

  • Distinct challenges facing the healthcare industry
  • Key factors driving new due diligence trends
  • Extensive polling and survey results from industry peers and leaders
  • Technology advances to ease the due diligence challenge

Here are some other items you might be interested in:

TTR Iberian Market - May 2021 Report

TTR's May M&A Report covering Portugal indicates a 10% decline in transaction volume compared to 2020 and EUR 3.71bn aggregate value. Read the report to find out more details about the state of M&A in Iberia.

Deal Drivers: AMERICAS Q1 2021

After a challenging year that saw deal activity freeze through H1 2020 as the outbreak of COVID-19 forced countries into lockdowns, the M&A market in the Americas has reset and recovered, posting steady deal numbers through Q1 2021. Aggregate deal value for the region reached US$658.73bn from 1,961 transactions announced in Q1 2021, up from US$236.77bn from 1,918 deals in the same period last year.

Invest in Insight: Private Equity Market Brief on Fundraising

Allocations to PE surged in the past decade, culminating in record sums committed to the asset class in the past few years. However, as the dealmaking landscape intensifies, how are PE firms adapting their strategies as they look toward the future? Our latest private equity market brief on fundraising takes a look at the key trends defining the past and present of PE fundraising, and what’s ahead.